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Pigh-Volume Hemofiltration
fter Out-of-Hospital Cardiac Arrest
Randomized Study
van Laurent, MD,* Christophe Adrie, MD,† Christophe Vinsonneau, MD,* Alain Cariou, MD,*
ean-Daniel Chiche, MD,* Alice Ohanessian, MD,‡ Christian Spaulding, MD,‡ Pierre Carli, MD,§
ean-François Dhainaut, MD, PHD,* Mehran Monchi, MD*
aris and Saint Denis, France
OBJECTIVES The study examined the effect of isovolumic high-volume hemofiltration (HF) alone or
combined with mild hypothermia (HT) on survival after out-of-hospital cardiac arrest
(OHCA) with initial ventricular fibrillation or asystole.
BACKGROUND Global inflammation in response to whole-body ischemia-reperfusion is common after
OHCA and may worsen the overall prognosis.
METHODS Sixty-one patients admitted between May 2000 and March 2002 in the intensive care units
of two hospitals in France were randomized to one of three groups: control, HF (200 ml/kg/h
over 8 h) or HFHT (32°C for 24 h) induced by cooling the HF substitution fluid. Standard
supportive care was provided in all three groups. The primary end point was survival with a
follow-up time of six months. The effect of HF on death by intractable shock was the
secondary end point.
RESULTS The six-month survival curves of the three groups were significantly different, with better
survival in the HF group (p  0.026) and in the HFHT group (p  0.018). After
adjustment on baseline characteristics of cardiac arrest, HF (with or without HT) was
associated with improved survival (logistic regression odds ratio, 4.4; 95% confidence interval
[CI], 1.1 to 16.6). Compared to control group, the relative risk of death by intractable shock
was 0.29 (95% CI, 0.09 to 0.91) in the HFHT group and 0.21 (95% CI, 0.05 to 0.85) in
the HF group.
CONCLUSIONS The HF may improve the overall prognosis after resuscitation from OHCA. Combination of
HF with mild HT is feasible and should be evaluated in larger trials. (J Am Coll Cardiol
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.04.0392005;46:432–7) © 2005 by the American College of Cardiology Foundation
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(espite recent advances in the management of out-of-hospital
ardiac arrest (OHCA) (1,2) the overall prognosis remains
oor. Over the last few years, it has been shown that treat-
ents, such as therapeutic hypothermia (HT) (32°C to 34°C),
tarted after restoration of spontaneous circulation (ROSC),
ay be of value for a better outcome (3,4).
A post-resuscitation syndrome, characterized by hyper-
hermia, hypotension, and multiple organ failure (5) is
robably the clinical expression of whole-body ischemia-
eperfusion injury occurring after ROSC in animals and
umans. Complement activation, cytokine release, expres-
ion of adhesion molecules, dysregulation of cytokine pro-
uction by leukocytes, presence of endotoxin in plasma (6),
nd adrenal dysfunction (7) have been described after
ardiac arrest. Thus, post-resuscitation syndrome shares
any features with severe sepsis (6,7), a fact that suggests
otential targets for new treatments. Systemic inflammation
fter OHCA was consistently present (6) and was associated
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ircuits, catheters, and replacement fluid concentrates were provided by GAMBRO
B, with an estimated cost of €120 per patient treated by hemofiltration.a
Manuscript received February 4, 2005; revised manuscript received March 18,
005, accepted April 13, 2005.ith delayed vasodilation and death by multiple organ
ailure (8). However, in these studies, early hemodynamic
ailure was not predictive of a poor neurological outcome,
nd many patients with early hemodynamic dysfunction had
good neurological outcome. This opens up the possibility
hat treatments capable of decreasing early mortality related
o intractable shock might result in a greater number of
urvivors with good neurological outcomes.
In experimental models of sepsis and ischemia-
eperfusion injury (9), isovolumic high-volume hemofiltra-
ion (HF) (200 ml/kg/h over 8 h) using a synthetic
igh-cutoff membrane removes medium molecular-weight
olecules responsible for ischemia-reperfusion injury (10)
nd improves myocardial performance, hemodynamics, and
urvival. This led us to hypothesize that HF may benefit
atients who recover spontaneous circulation after OHCA.
o evaluate this hypothesis, we conducted a randomized
tudy assessing the potential benefits of HF used alone or in
ombination with mild HT in patients admitted after
HCA.
ETHODS
tudy design. Patients admitted consecutively between
ay 2000 and March 2002 to the intensive care units
ICUs) of two hospitals (Cochin Teaching Hospital, Paris;
nd Delafontaine General Hospital, Saint Denis, France)
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August 2, 2005:432–7 High-Volume Hemofiltration After Cardiac Arrestere potentially eligible for the study if they had cardiac
rrest apparently related to heart disease. Additional inclu-
ion criteria were age between 18 and 75 years, initial
entricular fibrillation or asystole, estimated interval of 10
in from cardiac arrest to initiation of cardiopulmonary
esuscitation (no-flow interval), and interval of 50 min
rom initiation of cardiopulmonary resuscitation to ROSC
low-flow interval). Exclusion criteria were pregnancy, re-
ponse to verbal commands after ROSC, or a terminal
llness present before the cardiac arrest.
When acute myocardial infarction was the suspected
ause of OHCA, patients were first admitted to the cardiac
atheterization laboratory for coronary angiography, which
as performed according to standard techniques. As de-
cribed previously (2), when a recent coronary-artery occlu-
ion was found, coronary angioplasty was attempted, unless
he infarct-related artery was too small or the operator
onsidered the procedure to be technically impossible. The
atients were then transferred to the ICU.
A three-lumen central venous catheter was routinely
nserted at admission. Each patient had a femoral artery
atheter for arterial blood pressure monitoring and repeated
lood sample collection. Blood samples (4 ml) were col-
ected on sodium citrate and ethylene-diamine-tetra-acetate
t ICU admission (H0) and after 4, 8, 12, and 30 h. Blood
amples were immediately centrifuged at 1,500 g for 10 min
t 4°C, and the plasma was then stored at 70°C until
ssays of interleukin (IL)-6, complement components C3a
C3a), and the terminal complement complex (TCC). The
L-6 concentrations were determined using the ELISA kit
rom BioSource Systems (Camarillo, California), and the
CC and C3a levels were determined by using ELISA kits
rom Technoclone GmbH (Vienna, Austria).
A bladder catheter with a temperature probe was inserted
outinely to monitor urinary output and core temperature.
ll patients were sedated using intravenous midazolam (0.1
g/kg/h initially) and morphine (0.1 mg/kg/h initially)
uring the first 24 h in the ICU. Patients treated with
ypothermia were also given the neuromuscular blocker
ancuronium (1 to 4 mg/h).
The protocol was reviewed and approved by the ethics
Abbreviations and Acronyms
CI  confidence interval
C3a  complement compounds C3a
HF  isovolumic high volume hemofiltration
(200 ml/kg/h over 8 h)
HFHT  isovolumic high volume hemofiltration plus
hypothermia (32°C for 24 h)
HT  hypothermia
ICU  intensive care unit
IL  interleukin
OHCA  out-of-hospital cardiac arrest
ROSC  restoration of spontaneous circulation
TCC  terminal complement complexommittee of the Cochin Teaching Hospital (approval no. p657). As all patients were comatose, informed written
onsent was obtained as soon as possible from the patient’s
ext-of-kin; however, according to French law treatment
rials for immediate life-threatening situations, consent was
ot required to begin treatment. Patients who awoke with
ittle or no neurological impairment were informed of their
nclusion in the trial and asked whether they agreed to
rovide written informed consent.
reatment protocol. The study was designed as a prospec-
ive, randomized trial to compare three treatment strategies
fter OHCA: the control group received standard support-
ve care including mechanical ventilation, volume expan-
ion, and vasopressive drugs, as needed; the other two
roups received the same supportive treatment plus either
F alone (HF group) or HF combined with HT (HFHT
roup). At the time of our study, there were no published
ata supporting a beneficial role for HT after cardiac arrest;
hus, HT was not used in the control group.
Before the study, a computer-generated 1/1/1 random-
zation sequence was prepared for each center. Patients were
creened by an investigator immediately after the first call
rom the emergency responders (fire squadron or mobile
edical team). Those subjects who met the inclusion
riteria were randomly allocated to treatment using sealed
paque envelopes. This strategy was aimed at reducing the
nterval between OHCA onset and HF initiation, as 45 min
re needed to prepare and prime HF circuits. All random-
zed patients were analyzed, on an intention-to-treat basis.
F. The HF was achieved with a Gambro AK200-Ultra
achine (Gambro, Lund, Sweden) producing a sterile ultra-
ure substitution fluid (endotoxin 0.25 U/ml), which was
nfused into the bloodstream (on-line HF) before the filter
predilution mode). According to experimental data (9), an
ltrafiltration rate of 200ml/kg/h (limited to 12.5 l/h) was used
or 8 h. The ultrafiltrate was replaced by the same volume of
icarbonate-buffered (35 mmol/l) on-line produced fluid
zero-balance HF). The membrane used for HF was a 2.1 m2
igh-flux biocompatible polyamide dialyzer (POLYFLUX
1S, Gambro, Hechingen, Germany).
Vascular access for HF was via two single-lumen venous
atheters (8-F, 20 cm, Vygon, Ecouen, France) inserted in
wo different veins (femoral or jugular veins), allowing high
lood-flow rates (450 to 600 ml/min) with a minimal risk of
ecirculation. Anticoagulation was limited to an initial
ntravenous injection of 20 mg of enoxaparin.
In the HF group, the temperature of the replacement
uid was set at 37°C. In the HFHT group, the
emperature of the fluid was set at 30°C (the lowest
emperature allowed by the AK200U machine) and was
ecreased to 15°C by placing ice packs around the
nfusion line. When the target core temperature of 32°C
as reached, the ice packs were removed and a fluid
emperature of 30°C was used for the remaining HF
ime. At the end of HF, mild therapeutic HT (32°C to
3°C) was maintained by external cooling for 16 h, when
assive rewarming was started.
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High-Volume Hemofiltration After Cardiac Arrest August 2, 2005:432–7nd points. The primary end point was survival with a
ollow-up time of six months. To study the effect of HF
with or without hypothermia) on death by intractable
hock, we chose as the secondary end point the rate of death
y intractable shock in patients who had a favorable Glas-
ow coma scale (M5 or M6) or required sedation, making
eurological evaluation impossible. Survival with a favorable
eurological outcome was defined as a Pittsburgh cerebral-
erformance category of 1 (good recovery) or 2 (moderate
isability) on the five-category scale (11); patients in these
wo categories have sufficient brain function to live
ndependently.
tatistical analysis. Continuous variables, which were not
ormally distributed, were described as medians and inter-
uartile ranges and categorical variables as counts and
ercentages. Differences between groups at baseline were
nalyzed using the Kruskal-Wallis method or chi-square
est, as appropriate. The Kaplan-Meier method was used to
stablish the six-month survival plot, and probability values
or survival comparisons were calculated using the log-rank
tatistic. For the secondary end point, the relative risk of
eath by intractable shock was determined for the HF group
nd the HFHT group. Distributions of IL-6, C3a, and
CC were normalized by natural log transformation. After
atural log transformation, the Shapiro-Wilk W test was
sed to test for normality, with p values 0.10 indicating a
ormal distribution. Then, between-group comparisons for
L-6, C3a, and TCC were tested by two-way analysis of
ariance using mixed model methodology, with group and
ime as the factors.
We used a multivariate logistic regression model to look
or associations between HF and the primary and secondary
nd points after adjustment on classical baseline character-
stics of cardiac arrest (no-flow interval, low-flow interval,
nd initial rhythm). For this analysis, both the HF and
able 1. Baseline Characteristics of the Patients
Characteristic
Control Gro
(n  19)
ge, yrs 58 [53–64]
emale gender, n (%) 4 (21)
rrest witnessed, n (%) 19 (100)
istory of coronary heart disease, n (%) 2 (11)
nterval between collapse and first attempt at
resuscitation (min)
4 [2–8]
nterval between first attempt at resuscitation and
restoration of spontaneous circulation (min)
14 [10–15]
systole as the initial cardiac rhythm, n (%) 5 (26)
umber of shocks 3 [1–5]
ose of epinephrine during resuscitation 1 [0–3]
ypotension requiring continuous epinephrine on
hospital admission, n (%)
4 (21)
cute myocardial infarction, n (%) 9 (56)
emperature at ICU admission (°C) 35.7 [34.9–36
emperature 4 h after ICU admission (°C) 37.4 [37.1–38ontinuous variables are reported as (medians) and [interquartile ranges]. Categorical varia
HF  high-volume hemofiltration; HT  hypothermia; ICU  intensive care unit.FHT groups were pooled. Analyses were made using
tata 7 software (Stata Corp., College Station, Texas).
No data on the efficacy of high-volume HF after cardiac
rrest were available for a sample size calculation. Before
tudy initiation, sample size was estimated by assuming
ortality rates of 75% in controls and 45% with HF. With
lpha set at 0.05 and a power of 0.70, 30 patients were
eeded in each treatment group. We planned to include
onsecutive patients for three years. However, in February
002, two studies reported benefits from therapeutic HT
fter cardiac arrest (3,4). This led us to halt the study in
arch 2002 out of concern that absence of therapeutic HT
n the HF-only and control groups might be unethical.
ESULTS
uring the study period, 244 patients were assessed for
ligibility; 183 did not meet the inclusion criteria and 61
ere included in the study. Reasons for noninclusion were a
resumed noncardiac cause to the cardiac arrest in 82
atients; an estimated interval longer than 10 min from
ardiac arrest to initiation of cardiopulmonary resuscitation
n 71 patients; age above 75 years in 13 patients; response to
erbal command after ROSC in 12 patients; and terminal
llness in 5 patients. Baseline characteristics of the patients
re shown in Table 1. At baseline, the patients in the three
roups were similar, although a trend toward greater sever-
ty was seen in the HF group. Two patients (one in the HF
roup and one in the HFHT group) died before the
nitiation of HF. These patients were not excluded from the
nalysis.
As indicated in Table 1, 4h after ICU admission, the
edian core temperature in the HFHT group was 31.7°C
interquartile range 31.4°C to 32.5°C) and was always below
5°C, clearly lower than in the two other groups. After
atural log transformation, the p values of the Shapiro-Wilk
HF Group
(n  20)
HFHT Group
(n  22) p Value
52 [47–59] 56 [50–70] 0.18
4 (20) 4 (18) 0.97
20 (100) 22 (100) 0.99
6 (30) 3 (14) 0.22
5 [2–10] 4 [2–7] 0.79
25 [10–38] 16 [8–25] 0.11
5 (25) 6 (27) 0.98
3 [1–7] 3 [1–4] 0.38
6 [0–11] 3 [0–4] 0.09
8 (40) 6 (27) 0.41
9 (45) 9 (41) 0.38
36.0 [35.3–36.5] 36.0 [34.7–36.3] 0.60
37.3 [36.0–37.9] 31.7 [31.5–32.4] 0.0001up
.3]
.4]bles are reported as counts and percentages.
W
i
a
T
T
w
(
s
o
2
n
v
g
a
n
o
p
1
p
r
c
g
A
c
r
a
t
s
s
s
d
c
fl
p
a
p
I
H
i
D
I
s
s
t
i
i
w
a
or term
ICU 
F
0
h
c
435JACC Vol. 46, No. 3, 2005 Laurent et al.
August 2, 2005:432–7 High-Volume Hemofiltration After Cardiac Arresttest were 0.90 for IL-6, 0.88 for C3a, and 0.91 for TCC,
ndicating a normal distribution. No significant differences
cross groups for the biochemical data (IL-6, C3a, and
CC) obtained during the first 30 h (data are shown in
able 2).
Figure 1 shows the survival curves of the three groups,
ith a better survival in the HF (p  0.026) and HFHT
p  0.018) groups, compared to the control group. The
ix-month survival rates were 32% in the HFHT group (7
f 22 patients), 45% in the HF group (9 of 20 patients), and
1% (4 of 19 patients) in the control group (p  0.28). The
eurological outcome was favorable in all six-month survi-
ors. The hospital survival rate was very similar in the two
roups treated with HF (HF group: 9 of 20 patients, 45%;
nd HFHT group: 10 of 22 patients, 45%) and was
onsignificantly higher than the rate of the control group (5
f 19 patients, 26%, p  0.16).
Table 2. Biochemical Data
Variable Time Control
IL-6 (pg/ml) ICU admission 71 [47–
4 h 38 [28–
8 h 35 [19–
12 h 26 [18–
30 h 24 [18–
C3a (ng/ml) ICU admission 345 [268
4 h 228 [186
8 h 213 [141
12 h 203 [106
30 h 171 [85–
TCC (ng/ml) ICU admission 737 [590
4 h 785 [349
8 h 458 [214
12 h 433 [248
30 h 471 [263
Variables are reported as medians [interquartile ranges]. Two
(IL)-6; 0.17 for complement components C3a (C3a); 0.51 f
HF  high-volume hemofiltration; HT  hypothermia;
igure 1. Kaplan-Meier survival curves in each group (log-rank p 
.018). Patients treated by hemofiltration (HF) only (p  0.026) ors
emofiltration with hypothermia (HFHT) (p  0.018) differed signifi-
antly from patients in the control group.The rate of death by intractable shock (secondary end
oint) was 14% in the HFHT group (3 of 22 patients),
0% in the HF group (2 of 20 patients), and 42% (9 of 19
atients) in the control group (p  0.009). Thus, the
elative risk of death by intractable shock was 0.29 (95%
onfidence interval [CI] 0.09 to 0.91) in the HFHT
roup and 0.21 (95% CI 0.05 to 0.85) in the HF group.
fter adjustment on classical baseline characteristics of
ardiac arrest (no-flow interval, low-flow interval, and initial
hythm), the multivariate logistic-regression model showed
significant association between high-volume hemofiltra-
ion and both the primary end point (odds ratio for
ix-month survival 4.4; 95% CI 1.1 to 16.6) and the
econdary end point (odds ratio for death by intractable
hock 0.15, 95% CI 0.03 to 0.69).
Hypokalemia (3.5 mmol/l) was observed in 10 patients
uring HF (5 each in the HF and HFHT groups) and was
orrected by adding potassium-chloride to the substitution
uid. Hypophosphatemia (0.70 mmol/l) occurred in 20
atients (9 in the HF group and 12 in the HFHT group)
nd was corrected by intravenous infusion of disodium
hosphate, 8 mmol/h, during HF. During the first 24 h in
CU, ventricular tachycardia occurred in 6 patients in the
FHT group, in 2 patients in HF group, and 3 patients
n the control group (p  0.31).
ISCUSSION
n this prospective randomized study, HF after ICU admis-
ion for OHCA was associated with better six-month
urvival and a decreased risk of death from early intrac-
able shock. Although it is well established that prolonged
schemia results in tissue and organ damage, reperfusion-
nduced injury may also be harmful. In our previous studies,
e found that patients who were successfully resuscitated
fter cardiac arrest exhibited a systemic inflammatory re-
p HF Group HFHT Group
116 [63–331] 85 [41–577]
248 [40–3,668] 43 [40–576]
151 [33–1594] 42 [34–117]
55 [16–154] 24 [21–1,275]
17 [13–79] 30 [20–93]
524 [313–1,054] 531 [332–830]
371 [224–578] 301 [280–565]
347 [215–464] 228 [186–371]
223 [163–356] 236 [183–523]
253 [163–371] 282 [186–396]
7] 1048 [489–2,497] 815 [428–865]
9] 1384 [932–2,747] 718 [659–1,151]
840 [546–1,663] 512 [433–668]
630 [344–970] 437 [403–874]
725 [498–1,076] 588 [500–790]
nalysis of variance p for the group effect: 0.33 for interleukin
inal complement complex (TCC).
intensive care unit.Grou
128]
152]
77]
54]
32]
–535]
–371]
–374]
–357]
288]
–2,15
–1,10
–865]
–693]
–649]
-way aponse syndrome as early as 3 h after the ROSC (6). We
a
w
s
g
f
c
t
b
e
e
i
i
H
r
H
u
d
s
m
l
e
a
I
r
n
e
H
t
c
m
b
s
u
t
t
h
s
c
fi
T
t
a
f
t
c
w
t
s
H
n
a
n
t
o
w
a
f
v
o
g
q
i
i
e
i
p
a
B
t
i
p
a
t
a
w
r
p
y
e
p
t
c
c
s
i
g
a
h
h
e
d
b
i
E
t
a
i
1
p
fi
a
436 Laurent et al. JACC Vol. 46, No. 3, 2005
High-Volume Hemofiltration After Cardiac Arrest August 2, 2005:432–7lso found an increase in plasma endotoxin levels consistent
ith gut ischemia/reperfusion injury (6). Patients with a
ystemic inflammatory response often experience cardio-
enic and distributive shock leading to multiple organ
ailure and death within five days of the cardiac arrest (8). In
ontrast, after OHCA, late mortality is primarily ascribable
o brain damage (12). However, early hemodynamic insta-
ility may compromise cerebral blood flow, thereby wors-
ning the brain damage.
Experimental and clinical studies on the hemodynamic
ffects of HF have suggested that the efficacy of HF may be
ncreased by early use (13) and that high doses may be useful
n patients with sepsis syndrome (14). Consequently, the
F dose used in this trial (200 ml/kg/h) was based on
esults by Grootendorst et al. (9) who studied the efficacy of
F on gut ischemia-reperfusion injury. However, when
sed for long periods these high doses may markedly
ecrease the plasma levels of phosphorus and trace elements
uch as selenium and may compromise myocardial perfor-
ance. Therefore, in our study, the duration of HF was
imited to 8 h, on the basis of our previous study showing
arly onset of the systemic inflammatory response syndrome
fter OHCA (6).
In this study, we found no significant effect of HF on
L-6, C3a, or TCC levels. Other investigators have also
eported hemodynamic improvement with HF but no sig-
ificant changes in plasma cytokines (15). However, serum
ndothelin-1 concentrations were significantly reduced by
F (15). Endothelin-1 is now considered as a polyfunc-
ional cytokine with a proinflammatory effect. Plasma con-
entrations of endothelin-1 were negatively correlated with
ost indices of cardiac function and with mean arterial
lood pressure. This supports the hypothesis that other
oluble mediators may be implicated in hemodynamic fail-
re in humans after OHCA. Another hypothesis suggested
hat the effectiveness of HF is related to a cutting effect on
he peaks of these soluble mediators (16). Unfortunately, we
ave not determined the plasma peaks of endothelin-1.
One limitation of our study lies in the nature of the
tandard care used in the control group. Our study was
onducted before the publication of studies showing bene-
cial effects of mild therapeutic HT after OHCA (3,4).
hus, our controls did not receive therapeutic HT. When
he study was designed, we believed that patients admitted
fter a cardiac arrest needed a very fast cooling to benefit
rom HT. We believed that the best method for cooling
hese patients is intravenous injection of a high amount of
old fluid and for this reason, the study included a group
ith HT and HF. In Fact, the core temperature decrease in
he HFHT group seemed to occur faster than in the two
tudies of external cooling (3,4). The patients in our
FHT group received up to 12.5 l of cold fluid intrave-
ously per h, ensuring a rapid drop in core temperature. The
bove-mentioned studies (3,4) included only patients with
onperfusing ventricular tachycardia or ventricular fibrilla-
ion as the initial cardiac rhythm, and severity was greater in our study population, which included 16 (26%) patients
ith asystole. The survival rate in resuscitated patients with
systole as the initial cardiac rhythm in Europe is about 3%,
ar lower than in patients with ventricular tachycardia or
entricular fibrillation (17). Nevertheless, the survival rate in
ur control group (26%) was the same as in the control
roup of the Australian study (3), indicating that high-
uality standard care was provided to our patients.
However, without patient hypothermia, a better survival
n the HF group was observed. The increased survival rate
n the HF group without HT supports our working hypoth-
sis that HF may improve overall survival, possibly by
mproving early hemodynamic stability. Thus, HF may hold
romise as a complement to therapeutic HT in patients
dmitted after OHCA, even those with initial asystole.
oth HF and HT may have different but complementary
herapeutic targets, with HF reducing early hemodynamic
nstability and HT protecting against neurological im-
airment.
Another limitation of our study was that blinding to the
ssigned treatment was not feasible. However, we believe
hat full support was not inappropriately withdrawn from
ny of our patients, as all treatment limitation decisions
ere reached by consensus among ICU staff members,
egardless of the study group.
The third limitation of our study was the small number of
atients. We planned to include 90 patients during three
ears of this study, in the absence of previous data on the
fficacy of HF on our primary and secondary outcomes in
atients admitted after OHCA. However, publication of
he two studies reporting a benefit of therapeutic HT after
ardiac arrest led us to stop the enrollment, for ethical
onsiderations, after the inclusion of only 61 patients. The
mall sample size may have limited our ability to compare
mprovements and adverse effects in the two HF-treated
roups.
The fourth limitation of our study pertains to the gener-
lizability of our findings to other ICUs. In many ICUs,
emofiltration is now available. However, we used a high
emofiltration dose (200 ml/kg/h) that requires special
quipment. Use of high doses (up to 12.5 l/h) may be
ifficult without an online-produced solution.
Our study provides the first evidence that HF is clinically
eneficial in patients without renal failure. The yearly
ncidence of OHCA in the general population of the
uropean Union is about 9.5 per 10,000 inhabitants, and
he relative risk in individuals with cardiovascular disease is
bout 10 (17). About 10% of these patients meet the
nclusion criteria for therapeutic hypothermia studies and
5% meet those used in our study, in which we included
atients with initial asystole. Thus, early high-dose hemo-
ltration may be of value in patients admitted after OHCA
nd may constitute another step toward improving the
utcome of these patients.
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August 2, 2005:432–7 High-Volume Hemofiltration After Cardiac ArrestONCLUSIONS
arly HF after OHCA may decrease the risk of death from
ntractable shock and improve the final outcome. However,
efinite conclusions must await larger randomized clinical
rials testing the combination of HF with HT in a larger
ohort of OHCA survivors (11).
eprint requests and correspondence: Dr. Mehran Monchi, De-
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